115 related articles for article (PubMed ID: 15916851)
21. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
22. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.
Pawelczyk M; Baj Z; Chmielewski H; Kaczorowska B; Klimek A
Cerebrovasc Dis; 2009; 27(2):131-7. PubMed ID: 19047793
[TBL] [Abstract][Full Text] [Related]
23. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
24. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
[TBL] [Abstract][Full Text] [Related]
25. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis.
Williams JB; Jauch EC; Lindsell CJ; Campos B
Acad Emerg Med; 2007 Aug; 14(8):685-90. PubMed ID: 17606807
[TBL] [Abstract][Full Text] [Related]
26. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte-platelet aggregates in acute and subacute ischemic stroke.
Marquardt L; Anders C; Buggle F; Palm F; Hellstern P; Grau AJ
Cerebrovasc Dis; 2009; 28(3):276-82. PubMed ID: 19609079
[TBL] [Abstract][Full Text] [Related]
28. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic utility of S-100B protein and TPA in patients with ischemic stroke.
Kokocinska D; Wieczorek P; Partyka R; Jarzab J; Jałowiecki P; Sikora J
Neuro Endocrinol Lett; 2007 Oct; 28(5):693-8. PubMed ID: 17984926
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
31. [Hemostatic abnormalities in ischemic stroke].
Misz M; Oláh L; Kappelmayer J; Blaskó G; Udvardy M; Fekete I; Csépány T; Ajzner E; Csiba L
Orv Hetil; 1998 Oct; 139(42):2503-7. PubMed ID: 9810164
[TBL] [Abstract][Full Text] [Related]
32. Statin reduces the platelet P-selectin expression in atherosclerotic ischemic stroke.
Cha JK; Jeong MH; Kim JW
J Thromb Thrombolysis; 2004 Aug; 18(1):39-42. PubMed ID: 15744552
[TBL] [Abstract][Full Text] [Related]
33. Hyperresponsiveness of platelets in ischemic stroke.
Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
[TBL] [Abstract][Full Text] [Related]
34. Changes in fibrinolysis following exercise above and below lactate threshold.
Womack CJ; Rasmussen JM; Vickers DG; Paton CM; Osmond PJ; Davis GL
Thromb Res; 2006; 118(2):263-8. PubMed ID: 16081145
[TBL] [Abstract][Full Text] [Related]
35. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
36. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
37. Soluble but not platelet P-selectin correlates with spontaneous platelet aggregation: a pilot study.
Cleanthis M; Smout J; Bhattacharya V; Ashour H; Dyker A; Ford GA; Mikhailidis DP; Stansby GP
Clin Appl Thromb Hemost; 2008 Apr; 14(2):227-33. PubMed ID: 18252728
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke.
Ilhan D; Ozbabalik D; Gulcan E; Ozdemir O; Gülbaçs Z
Neurologist; 2010 May; 16(3):188-91. PubMed ID: 20445428
[TBL] [Abstract][Full Text] [Related]
39. Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology?
Oberheiden T; Nguyen XD; Fatar M; Elmas E; Blahak C; Morper N; Dempfle CE; Hennerici M; Borggrefe M; Kälsch T
Clin Appl Thromb Hemost; 2012; 18(1):87-91. PubMed ID: 21733938
[TBL] [Abstract][Full Text] [Related]
40. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
